Location
United States, North America
Cheque size
$2M - $50M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Pharmaceuticals
About Investor
Matthew McAviney is a Partner at Monograph Capital, based in San Francisco, where he focuses on company formation and early-stage biopharma investing. He has helped form and develop more than 30 biotechnology companies, including Ouro Medicines, Escient Pharmaceuticals, Denali Therapeutics, Apellis Pharmaceuticals, Mirum Pharmaceuticals, and Cogent Biosciences. Before joining Monograph in 2026, he spent more than 10 years at NEA and F-Prime focused on biopharma and healthcare investing.
Previous investments
Ouro Medicines
120M |2025
AviadoBio
78M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,FB
Frank Balas
Canada, North America
$100K - $5M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
